![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of RMDN1 mRNA] | CTD | PMID:31150632 | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:1606009 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RMDN1 mRNA | CTD | PMID:22079256 | 1,2-dimethylhydrazine | decreases expression | ISO | RGD:1624014 | 6480464 | 1, 2-Dimethylhydrazine results in decreased expression of RMDN1 mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | multiple interactions | ISO | RGD:1624014 | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RMDN1 mRNA | CTD | PMID:22206623 | 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | affects localization | ISO | RGD:1606009 | 6480464 | Metribolone affects the localization of RMDN1 protein | CTD | PMID:17440980 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of RMDN1 mRNA | CTD | PMID:33387578 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:1606009 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RMDN1 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RMDN1 mRNA | CTD | PMID:28628672 | 4,4'-sulfonyldiphenol | increases expression | ISO | RGD:1606009 | 6480464 | bis(4-hydroxyphenyl)sulfone results in increased expression of RMDN1 protein | CTD | PMID:34186270 | 4-hydroxyphenyl retinamide | increases expression | ISO | RGD:1624014 | 6480464 | Fenretinide results in increased expression of RMDN1 mRNA | CTD | PMID:28973697 | acetamide | decreases expression | EXP | | 6480464 | acetamide results in decreased expression of RMDN1 mRNA | CTD | PMID:31881176 | aconitine | decreases expression | EXP | | 6480464 | Aconitine results in decreased expression of RMDN1 protein | CTD | PMID:33236894 | aflatoxin B1 | increases methylation | ISO | RGD:1606009 | 6480464 | Aflatoxin B1 results in increased methylation of RMDN1 gene | CTD | PMID:27153756 | aflatoxin B1 | decreases methylation | ISO | RGD:1606009 | 6480464 | Aflatoxin B1 results in decreased methylation of RMDN1 intron | CTD | PMID:30157460 | Aflatoxin B2 alpha | decreases methylation | ISO | RGD:1606009 | 6480464 | aflatoxin B2 results in decreased methylation of RMDN1 intron | CTD | PMID:30157460 | amphetamine | increases expression | EXP | | 6480464 | Amphetamine results in increased expression of RMDN1 mRNA | CTD | PMID:30779732 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of RMDN1 mRNA | CTD | PMID:25181051 | bisphenol A | decreases expression | ISO | RGD:1606009 | 6480464 | bisphenol A results in decreased expression of RMDN1 protein | CTD | PMID:34186270 | bisphenol A | multiple interactions | ISO | RGD:1606009 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RMDN1 mRNA | CTD | PMID:28628672 | Bisphenol B | increases expression | ISO | RGD:1606009 | 6480464 | bisphenol B results in increased expression of RMDN1 protein | CTD | PMID:34186270 | bisphenol F | multiple interactions | ISO | RGD:1606009 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RMDN1 mRNA | CTD | PMID:28628672 | bisphenol F | increases expression | ISO | RGD:1606009 | 6480464 | bisphenol F results in increased expression of RMDN1 protein | CTD | PMID:34186270 | cadmium atom | increases expression | ISO | RGD:1606009 | 6480464 | Cadmium results in increased expression of RMDN1 mRNA | CTD | PMID:24376830 | cadmium dichloride | decreases methylation | EXP | | 6480464 | Cadmium Chloride results in decreased methylation of RMDN1 promoter | CTD | PMID:22457795 | carbon nanotube | decreases expression | ISO | RGD:1624014 | 6480464 | Nanotubes, Carbon results in decreased expression of RMDN1 mRNA | CTD | PMID:25620056 | cobalt dichloride | decreases expression | ISO | RGD:1606009 | 6480464 | cobaltous chloride results in decreased expression of RMDN1 mRNA | CTD | PMID:19376846 | copper(II) sulfate | decreases expression | ISO | RGD:1606009 | 6480464 | Copper Sulfate results in decreased expression of RMDN1 mRNA | CTD | PMID:19549813 | cyclosporin A | decreases expression | ISO | RGD:1606009 | 6480464 | Cyclosporine results in decreased expression of RMDN1 mRNA | CTD | PMID:25562108 | dexamethasone | multiple interactions | ISO | RGD:1606009 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RMDN1 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RMDN1 mRNA | CTD | PMID:28628672 | dicrotophos | decreases expression | ISO | RGD:1606009 | 6480464 | dicrotophos results in decreased expression of RMDN1 mRNA | CTD | PMID:28302478 | dioxygen | multiple interactions | ISO | RGD:1624014 | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RMDN1 mRNA | CTD | PMID:30529165 | folic acid | multiple interactions | ISO | RGD:1624014 | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RMDN1 mRNA | CTD | PMID:22206623 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of RMDN1 mRNA | CTD | PMID:33387578 | indometacin | multiple interactions | ISO | RGD:1606009 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RMDN1 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RMDN1 mRNA | CTD | PMID:28628672 | isotretinoin | decreases expression | ISO | RGD:1606009 | 6480464 | Isotretinoin results in decreased expression of RMDN1 mRNA | CTD | PMID:20436886 | ivermectin | decreases expression | ISO | RGD:1606009 | 6480464 | Ivermectin results in decreased expression of RMDN1 protein | CTD | PMID:32959892 | methylmercury chloride | decreases expression | ISO | RGD:1606009 | 6480464 | methylmercuric chloride results in decreased expression of RMDN1 mRNA | CTD | PMID:28001369 | methylparaben | decreases expression | ISO | RGD:1606009 | 6480464 | methylparaben results in decreased expression of RMDN1 mRNA | CTD | PMID:31745603 | paracetamol | decreases expression | ISO | RGD:1606009 | 6480464 | Acetaminophen results in decreased expression of RMDN1 mRNA | CTD | PMID:21420995 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of RMDN1 mRNA | CTD | PMID:33387578 | pentachlorophenol | increases expression | ISO | RGD:1624014 | 6480464 | Pentachlorophenol results in increased expression of RMDN1 mRNA | CTD | PMID:23892564 | perfluorooctanoic acid | increases expression | ISO | RGD:1606009 | 6480464 | perfluorooctanoic acid results in increased expression of RMDN1 protein | CTD | PMID:26879310 | phenobarbital | decreases expression | ISO | RGD:1624014 | 6480464 | Phenobarbital results in decreased expression of RMDN1 mRNA | CTD | PMID:23091169 | potassium chromate | decreases expression | ISO | RGD:1606009 | 6480464 | potassium chromate(VI) results in decreased expression of RMDN1 mRNA | CTD | PMID:22079256 | potassium chromate | multiple interactions | ISO | RGD:1606009 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RMDN1 mRNA | CTD | PMID:22079256 | resveratrol | multiple interactions | ISO | RGD:1606009 | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of RMDN1 mRNA | CTD | PMID:23557933 | silicon dioxide | decreases expression | ISO | RGD:1624014 | 6480464 | Silicon Dioxide results in decreased expression of RMDN1 mRNA | CTD | PMID:19073995 | sodium arsenate | increases expression | ISO | RGD:1624014 | 6480464 | sodium arsenate results in increased expression of RMDN1 mRNA | CTD | PMID:21795629 | sunitinib | decreases expression | ISO | RGD:1606009 | 6480464 | Sunitinib results in decreased expression of RMDN1 mRNA | CTD | PMID:31533062 | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of RMDN1 mRNA] | CTD | PMID:31150632 | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of RMDN1 mRNA | CTD | PMID:31150632 | tetraphene | increases expression | ISO | RGD:1624014 | 6480464 | benz(a)anthracene results in increased expression of RMDN1 mRNA | CTD | PMID:26377693 | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of RMDN1 mRNA | CTD | PMID:23411599, PMID:34492290 | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of RMDN1 mRNA | CTD | PMID:33387578 | trovafloxacin | decreases expression | ISO | RGD:1624014 | 6480464 | trovafloxacin results in decreased expression of RMDN1 mRNA | CTD | PMID:35537566 | tungsten | increases expression | ISO | RGD:1624014 | 6480464 | Tungsten results in increased expression of RMDN1 mRNA | CTD | PMID:30912803 | valproic acid | increases expression | ISO | RGD:1606009 | 6480464 | Valproic Acid results in increased expression of RMDN1 mRNA | CTD | PMID:23179753, PMID:28001369 | valproic acid | affects expression | ISO | RGD:1606009 | 6480464 | Valproic Acid affects the expression of RMDN1 mRNA | CTD | PMID:25979313 | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of RMDN1 mRNA | CTD | PMID:23034163 | vorinostat | increases expression | ISO | RGD:1606009 | 6480464 | vorinostat results in increased expression of RMDN1 mRNA | CTD | PMID:27188386 | |